General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-01 | 2024-06 | 1.58 | N/A | N/A | N/A |
2024-04-25 | 2024-03 | -1.49 | -1.32 | 0.17 | 11.41% |
2024-02-06 | 2023-12 | 1.76 | 1.72 | -0.04 | -2.27% |
2023-11-07 | 2023-09 | 1.91 | 2.29 | 0.38 | 19.90% |
2023-08-03 | 2023-06 | 1.6 | 1.34 | -0.26 | -16.25% |
2023-04-27 | 2023-03 | 1.63 | 1.37 | -0.26 | -15.95% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-07 | B of A Securities | Upgrade | Neutral | Buy |
2023-09-05 | Truist Securities | Upgrade | Buy | Buy |
2023-09-05 | HSBC | Upgrade | Reduce | |
2023-09-05 | Truist Securities | Upgrade | Buy | Buy |
2023-08-08 | Benchmark | Upgrade | Buy | Buy |
2023-08-03 | RBC Capital | Upgrade | Sector Perform | Sector Perform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-05-07 | BARTON JACQUELINE K | Director | 24.54K | Stock Award(Grant) |
2024-03-07 | DICKINSON ANDREW D | Chief Financial Officer | 134.98K | Conversion of Exercise of derivative security |
2024-05-07 | LOVE TED WENDELL | Director | 2.82K | Stock Award(Grant) |
2024-05-07 | MANWANI HARISH | Director | 12.87K | Stock Award(Grant) |
2024-03-07 | MERCIER JOHANNA | Officer | 118.43K | Conversion of Exercise of derivative security |
2024-03-07 | O'DAY DANIEL PATRICK | Chief Executive Officer | 484.85K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 126.19M | 9.73B | 10.13% |
2023-06-29 | Vanguard Group Inc | 113.37M | 8.74B | 9.10% |
2023-06-29 | Capital World Investors | 80.93M | 6.24B | 6.50% |
2023-06-29 | State Street Corporation | 59.32M | 4.57B | 4.76% |
2023-06-29 | Capital Research Global Investors | 57.90M | 4.46B | 4.65% |
2023-06-29 | Dodge & Cox Inc | 33.98M | 2.62B | 2.73% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 38.97M | 3.00B | 3.13% |
2023-09-29 | Income Fund of America Inc | 34.44M | 2.58B | 2.76% |
2023-06-29 | Vanguard 500 Index Fund | 29.70M | 2.29B | 2.38% |
2023-06-29 | Dodge & Cox Stock Fund | 24.24M | 1.87B | 1.95% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 21.14M | 1.62B | 1.70% |
2023-09-29 | Washington Mutual Investors Fund | 20.14M | 1.51B | 1.62% |
Dividend | Date |
---|---|
0.77 | 2024-06-14 |
0.77 | 2024-03-14 |
0.75 | 2023-12-14 |
0.75 | 2023-09-15 |
0.75 | 2023-09-14 |
0.75 | 2023-06-14 |
Split | Date |
---|---|
2 : 1 | 2013-01-28 |
2 : 1 | 2007-06-25 |
2 : 1 | 2004-09-07 |
2 : 1 | 2002-03-08 |
2 : 1 | 2001-02-22 |
Thx $DADDY for the pump $GILD: According to a 2017 financial disclosure form filed with the U.S. Office of Government Ethics in June 2017, Trump had a capital gain of $50,001 to $100,000 for Regeneron Pharmaceuticals and $100,001 to $1 million for Gilead Sciences Inc. https://www.usatoday.com/story/money/2020/10/03/trump-walter-reed-treatment-president-regeneron-gilead-remdesivir/3610111001/
He is been taking all available treatments. 10 docs with each a few good ideas.
Perfect guinea pig.
Pros.
Permanent coloring of the skin. Mostly fluorescent orange with some green spasms
Tax rebate for scientific collaboration as opposed to Russian collaboration
Cons.
TBD
Stock market? Do you feel lucky today?
Big daddy pumping $GILD
Im here mainly bc of the 5 yr chart showing this bottom.
$3120 $GILD per patient, cuts hospital stay from 15 days to 11 days, which makes the price justified because its still cheaper than spending a single day in a hospital. Thanks $AMZN from $WaPo owned by Bezos: https://www.washingtonpost.com/business/2020/09/30/remdesivir-drug-coronavirus-gilead/
If u got a load boys and girls $GILD come on it! We use Remdesivir all the time. So excited. That drug alone is worth $1,000,000,000’s esp w COVID-19 spiking. 1,000,000 dead w a spike ahead of flu season
$GILD AS YOU GUYS KNOW $GILD HAD DOUBLE BOTTOM YESTERDAY AND SMART MONEY AND INSTITUTIONAL BUYING IN. NEXT PHASE WILL BE PUBLIC PARTICIPATION AND THEN EXCESS PHASE. BASE ON TECHNICAL CHART $GILDLEAD READY FOR A BREAK OUT. NEXT LEVEL SHOULD BE $74 THEN $88. FLOAT LOOKING GOOD SO IT WILL MOVE UP SLOWLY AND STEADILY FROM HERE. GOOD LUCK EVERYONE
I knew there was a reason I held $GILD all through its flat price this year other than Remdesivir. Big positive move https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777
Please cover shorts
I have 17k worth of calls expiring next week. I need this puppy to fly
$GILD My guess is red to green tomorrow.
Damn. This company truly is a massive bag of shit.